Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Bullboard Posts
Post by roadster8on Oct 23, 2018 10:25am
106 Views
Post# 28855397

Opinions Situation

Opinions Situation
The popularity of legalization has created an insane cannabis stock hype. There was a Golddiggerhype, which was over once with the legalization. Many have taken their profits directly. Added to this are panic sales. The whole hype reminded a bit of the cryptocurrency bubble. The market is based on rough estimates in many reports, which again creates uncertainty for investors. However, here is a real market, with a real product. Now counts sales figures and corporate profits. If positive, they will correct uncertainties with upcoming quarterly figures. Even if empty shelves and bottlenecks have a positive effect, this can also be negative for investors. No sophisticated sales market, and no optimized supply strategy. The market has yet to normalize. With RQB is added that they are still waiting for the license, which is currently not conducive. In my view, there is still a huge growth potential of the market, although the current market has already been sufficient to bring the supply system to a standstill. Canada has taken a pioneering role. The neighbor USA and others will follow suit. Canadian companies are likely to have a competitive edge to play. I am long invested and will continue to buy after the stocks have bottomed out. But also for people who are short invested, the up and down should be. I'm watching and buying and will see where the journey is going in 2020. Just my opinion!
Bullboard Posts